|
DMAA Drugs Made In America Acquisition Corp 2028614 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$1,970,459.00 |
| Balance Sheet |
|
Current Assets
|
$14,887.00 |
|
Assets
|
$242,035,303.00 |
|
Current Liabilities
|
$492,169.00 |
|
Liabilities
|
$7,392,169.00 |
|
Equity
|
$-7,377,282.00 |
|
Shares Out
|
10717143.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-91,250.00 |
|
Investing Cash Flow
|
$-231,150,000.00 |
| Market Analysis |
Market Cap
|
$114,780,601.53 |
|
Price
|
$10.71 |
|
PB
|
2.14 |
|
EPS
|
-0.03 |
|
PE
|
47.95 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DMAA documents filed with the SEC.
DMAA Filings
Clear
